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LIST OF ABREVIATIONS 
C18 GravitySB (C18 GSB) – liquid chromatography C18-based column GravitySB™ 
C18 Isis – liquid chromatography C18-based column Isis™ 
c-AMP-CMP (cACMP) – cyclic adenosine monophosphate cytosine monophosphate 
c-AMP-GMP (cAGMP) – cyclic adenosine monophosphate guanosine monophosphate 
c-AMP-UMP (cAUMP) – cyclic adenosine monophosphate uridine monophosphate 
c-CMP-GMP (cCGMP) – cyclic cytosine monophosphate guanosine monophosphate 
c-CMP-UMP (cCUMP) – cyclic cytosine monophosphate uridine monophosphate  
c-di-AMP – cyclic diadenosine monophosphate 
c-di-CMP – cyclic dicytosine monophosphate  
c-di-GMP – cyclic diguanosine monophosphate  
c-di-NMP (CDN) – cyclic dinucleotide monophosphate 
c-di-UMP – cyclic diuridine monophosphate 
c-GMP-UMP (cGUMP) – cyclic guanosine monophosphate uridine monophosphate 
HPLC – high-performance liquid chromatography 
LC-MS – liquid chromatography – mass spectrometry 
LOD – limit of detection 
NMR – nuclear magnetic resonance 
OD600 – optical density at wavelength of 600 nm  
PDE – phosphodiesterase   
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INTRODUCTION 
Nucleotides, besides being monomers of nucleic acids, are widespread second 
messengers of all the cellular organisms. Among them, a new group – cyclic dinucleotides 
(CDN) – is recently getting high attention, as the processes, they take part in, are found to be 
highly important for organisms (Romling et al. 2013; Sun et al. 2013; Huynh and Woodward 
2016). Currently, only three of these compounds were confirmed in living cells (Kalia et al. 
2013). The methods for their identification are varying and do not allow to compare directly 
the amount of compounds between them, as well as, they are not optimized to work with 
several of the compounds (Spangler et al. 2010; Gao et al. 2015). Another important point, is 
that currently the field of the cyclic dinucleotides is rapidly expanding and the new proteins, 
predicted to utilize CDNs are discovered literary every day (Krasteva et al. 2012; Tschowri 
2016; Hallberg et al. 2016). However, many of them do not show activity towards known 
compounds or their metabolites (Huynh and Woodward 2016). This suggests possible 
presence of different compounds of cyclic dinucleotides group in living cell. 
Therefore, it is important to develop a method, that can reveal such compounds and be 
ubiquitous towards all known and proposed cyclic dinucleotide compounds. In addition, as 
without highly pure standard materials it is hard to set up high-precision quantification 
method, it is still possible to develop one for preliminary identification of such compounds in 
cells for later biological use. 
Based on said, the aims of the study are the following:  
- Set up the experimental method to analyze mixture of synthetic cyclic dinucleotide 
compounds, 
- Develop sample preparation and bacteria growing procedure to keep possible 
compounds intact, 
- Perform analysis of living cells to confirm the ability of the method to identify 
known compounds and the candidates for new ones.  
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1. LITERATURE OVERVIEW 
1.1. Historical Perspective 
Nucleic acids and their monomers – nucleotides – have been playing central role in all 
the living organisms throughout the whole history of life. From the simplest RNA-like 
oligomers and triphosphates to all the currently known and still unknown forms, these 
molecules were and still are guiding the development of all biota. Not only the genetic 
information storage is the feature of these compounds, but also variety of metabolic and 
signaling functions. 
The first important step was discovery of ATP (adenosine-triphosphate) and its 
functions by Karl Lohmann 1929 and Fritz Albert Lipmann 1941 respectively (Florkin 1991). 
These discoveries gave the biological society the first good candidate for the energy source of 
the mammals (later, all the cellular forms of life). Later other triphosphonucleotides where 
shown to have the similar functions. 
DNA primal structure, discovered by James Watson and Francis Crick in 1953, whose 
model-building efforts were guided by X-ray diffraction data, was a milestone in the whole 
biological approach and started the new branch of Life science – molecular biology (Lehmann 
2003). 
Next key point was the discovery of adenosine-containing compound that initiates 
cellular response to epinephrine and glucagon in liver homogenate. Using UV-spectroscopy, 
E. Sutherland and coauthors showed that the ratio of ribose, adenosine and phosphate in this 
compound was 1:1:1. Later on, by inserting synthetic cAMP (cyclic adenosine 
monophosphate) precursor, it was confirmed, that this was the second messenger for this 
reaction (Sutherland et al. 1968). Few years later, second cyclic messenger cGMP (cyclic 
guanosine monophosphate) was discovered. 
At that moment most of the research was centered on Eukaryotic kingdom of life. 
However, (Ross et al. 1987) showed, that in Prokaryotic organisms similar processes can take 
place. For the formation of cellulose by Acetobacter xylinum, allosteric cofactor c-di-GMP 
(cyclic diguanosine monophosphate) was produced by the bacteria. Unfortunately, for 
decades it was completely ignored by microbiologists. Later it was shown, that this compound 
plays key role as second messenger in a lot of various (biofilm formation, motility, virulence, 
the cell cycle, differentiation, etc.) processes in different bacterial species (Romling et al. 
2013; Krasteva et al. 2012).  
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In 1993, cAMP was also shown to function in bacteria as well as ppGpp (tetraphospho-
guanosine) (Potrykus and Cashel 2008; Kolb et al. 1993) Until 2008, c-di-GMP was the only 
cyclic dinucleotide known. The novel c-di-AMP (cyclic diadenosine monophosphate) was 
found together with its cyclase protein (DUF147, later named as DAC), nevertheless the 
function remained unknown. Later it was suggested to play role in DNA damage control 
during cell-cycle checkpoints (Romling 2008; Bejerano-Sagie et al. 2006; Witte et al. 2008; 
Romling et al. 2013). 
Last key point emerged quite recently. Novel asymmetric molecules, c-AMP-GMP 
(Cyclic guanosine [3`→5`] / [2`→5`] monophosphate–adenosine [3`→5`] monophosphate), 
were found in mammalian cells and as a product of Vibrio cholerae metabolism. The function 
of the first one is to control bacterial and viral infection via binding (as well as other known c-
di-NMPs) to STING protein, which triggers interferon response, while the second takes part 
in pathogenic pathways (Wu et al. 2013; Gao et al. 2015). The structural inequality was 
studied by NMR and all three currently known proteins for c-AMP-GMP synthesis produce 
only 2`3` structure and only very recent studies reveal first 3`3` cyclase (Gao et al. 2013; 
Hallberg et al. 2016). 
Thus their recent identification, the c-di-NMPs could be a huge piece of the puzzle, 
which is the metabolism of Prokaryotes. 
1.2. Cyclic dinucleotides structure and mechanism of functioning 
The discovery of each of the currently known c-di-NMP was serendipitous and, at least 
in case of c-di-NMP, quite underestimated.  
Cellulose biosynthesis in A. xylinum (currently Gluconacetobacter xylinum) was 
thought as a simplified model of this process in plants. Surprisingly, the purified cellulose 
synthase showed much lower activity, in comparison with whole untouched cells as well, as 
whole membrane fraction. That suggested that there was some cofactor inside the cell or in 
the membrane. Purified protein crystal contained some specific form of guanosine-phosphate 
at ligand-binding site. Later, using NMR, Ross et al. (1987) showed, that both synthetic c-
di[3`5`]-GMP and natural ligand had the same coupling constant and all the peaks were the 
same. Its structure is shown on Figure 1. 
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Unlike linear oligonucleotides, the compound is stable in pH range of 3-10 (standard 
conditions, tested for 1 hour) and it was thermally stable (100°C), and did not degrade in 
human serum after 24h (Hyodo and Hayakawa 2008). That could be explained by mutual 
protection of the phospho-group via its linkage to 5` position on the paring ribose. This lead 
to low flexibility and, consequently, prevents from attack on the 2` OH group. 
Another feature of c-di-GMP is its spontaneous stacking. By now it is found that the 
compound can form dimers (Fig. 2.), stabilized by H-bonds, which also takes part in signal 
transduction; tetra-, octa- and higher oligomers are reported, however their biological function 
remains unknown (Zhang et al. 2006). 
 
Figure 2. Different non-covalent staking forms of c-di-GMP. C-di-GMP dimer form. Carbon atoms shown 
in green, Nitrogen – blue, Oxygen – red, Phosphorus – orange and Hydrogen – grey (Romling et al. 2013). 
Oligomeric forms of c-di-GMP: a – dimer, b – tetramer, c – octamer. Both forms are shown to be present 
in natural and synthetic samples (Zhang et al. 2006). 
Unlike c-di-GMP, other natural compounds of this class have not been reported to form 
any oligomeric structures. For c-di-AMP, it is considered to be due to the lack of oxygen in 
the second position of nucleobase and for c-AMP-GMP it is speculated to be linked with the 
Figure 1. Structure of c-di-GMP. The structure resembles two ribo-guanosine monophosphates, 
linked with each other by phosphate groups in position [3 →5] of the cyclic sugars, the molecule is 
symmetric, it has two phosphate groups and two amino groups, which can be easily ionized (National 
Center for Biotechnology Information 2016). 
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asymmetry of both nucleobases and phosphate linkage. Such asymmetry between phosphate 
and ribose in c-AMP-GMP molecule was quite controversial: original discovery paper 
reported it to be symmetrical [3` →5`] molecule, however all the NMR spectra of the purified 
molecule showed additional peaks, which could be explained either as a mixture of two 
symmetrical isomers or on asymmetrical. The latter was confirmed by additional investigation 
(Gao et al. 2015). 
Specific structure of the molecule requires very distinct enzymes for both natural 
synthesis and degradation. These enzymes have specific motifs in their active sites, which 
react only to the molecule or its precursor with high specificity, though, some side products 
are demonstrated (Schirmer and Jenal 2009; Paul et al. 2010). It is also quite frequent, that the 
protein has both domains – GGDEF (cyclase activity) and EAL (phosphodiesterase activity) – 
on the single molecule. However, the combination of GGDEF and HD-GYP – which is 
another phosphodiesterase domain – is not reported (Fig.3.). Such construction suggests, that 
effects of the compound should be localized, which goes well with the diversity of the 
processes, c-di-NMPs are involved in (He et al. 2016; Krasteva et al. 2012). 
 
Figure 3. Generalized scheme of c-di-NMP pathway (example of c-di-GMP). The precursor is always the 
molecule of one class – 2 NTP, which through 2-step reaction is turned to corresponding cyclic 
dinucleotide. In of PDE (phosphodiesterase), there are two possibilities: EAL-domain will break one 
[3`→5`]-bond, while HD-GYP will go further and produce two separated GMPs (Schirmer and Jenal 
2009). 
These domains are highly conservative between different bacterial species and STING 
proteins in mammals, suggesting that it has significant importance for the bacterial 
metabolism and adaptation abilities (Gao et al. 2015). 
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As to main targets of c-di-NMP, besides EAL/HD-GYP degraded domain proteins they 
are PilZ-domain proteins and riboswitches – small specific RNA molecules. PilZ domain 
proteins were predicted directly upon discovery of c-di-GMP (Romling et al. 2013). They are 
transcriptional factors and were described in various bacteria, including E. coli (flagellum 
functioning, biofilm formation), C. crescentus (flagellum functioning), V. cholerae (biofilm 
formation, virulence) (Römling 2002; Tischler and Camilli 2005). As to riboswitches – a 
specific family of this RNAs, that can modulate gene expression, when bound with ligand – 
was found to react exclusively on c-di-GMP presence, even in vitro, which is a rear case. The 
sequences are reported to be upstream of pde or dgc genes’ sequences that suggests their 
involvement in feedback control of the CDN amount. Unfortunately, mechanisms, in which 
these riboswitches are involved are still unknown, but presumed, that they could be involved 
in stress response (Romling et al. 2013; Sudarsan et al. 2008; Kalia et al. 2013). 
On the contrary, mammalian c-AMP-GMP has specific target – STING protein that 
reacts to all the known c-di-NMPs, but in different site. The pathway is interesting in the 
point, that the compound is distinguished from other CDNs of bacterial origin. Mammalian c-
AMP-GMP if produced as the response to free double strain DNA in cytoplasm of cells (Sun 
et al. 2013; Hallberg et al. 2016). 
For development and further identification, it is of great importance to have chemical 
methods and instrumentation. Biological methods were and still are useful to get functional 
information of the ligand and targets, as well as pathway discovery. However, when it comes 
to structure identification and confirming the identity of compound, the chemical 
methodology is incomparably more advantageous. 
1.3. Reported methods of identification of cyclic dinucleotides. 
Many instrumental and non-instrumental methods have arisen in recent years and most 
of them are targeted for c-di-GMP. LC-MS is still the most widespread method for 
identification of the substance. However, some properties of c-di-GMP allow to identify its 
small amount in solution with help of titrimetry. The method, based on the thiazole orange 
property of fluorescence, which is remarkably enhanced in complex with quadruplex of c-di-
GMP, was developed previously (Nakayama et al. 2011). Another method, also developed by 
this group, was the use of hemin and proflavine to aggregate c-di-GMP with Peroxidase. This 
gives a way to use simple colorimetry for the molecule. Such methods showed quite low 
detection limit of 5 and 1 µM respectively. These methods are quite robust and fast, and, what 
is of high importance, they are particularly specific for c-di-GMP. There was no report, 
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concerning detection of other CDNs, that combines with the fact of no reported non-covalent 
interactions of other molecules of the class (Nakayama et al. 2012).  
Another complexing-based semi-quantitative titrimetric analysis method was developed 
with the help of specific diamidinium/iminium aromatic compounds in presence of K
+
/Li
+
 as 
complexing molecules. The results were measured using CD-spectra of initial solution and 
solution of complexes. Authors showed, that two molecules of the tested group (diminazene 
actuate and auramine O) incorporate at least 50% of c-di-GMP from solution and the presence 
of c-di-GMP can easily be detected by the method (Kelsey et al. 2012). The drawback is CD 
of complex samples and, even if to use another method for detection, the complexing may 
lead to further polymerization of c-di-GMP, forming chains of tetramers.  
One more sophisticated way, is incorporating above mentioned riboswitches, that was 
shown by Zhou et al. (2016). For the investigation, they used natural I type riboswitches for 
control of lac operon in E. coli. Such riboswitches use two molecules in (trans-) dimer 
configuration, shown above. Authors showed, that use of one modified c-di-GMP-dependent 
riboswitch gave 16% difference between control and mutant strains in galactose catabolizes 
after addition of c-di-GMP. Incorporation of two riboswitches to regulate lacZ gave up to 
50% difference. While being highly specific and having low detection limits, method is not 
enough reproducible and is too complicated for routine analysis. 
As to LC-MS methods, the most widespread is one, described by Spangler et al. (2010), 
which is set as well established and specific enough for use in biological research. The 
method was used for c-di-GMP identification and quantitation in E. coli and some other 
bacteria. For LC they used C18 pyramid column with several column guards. Eluent A was 
water with 10mM ammonium acetate and 0.1% acetic acid and eluent B – pure methanol. For 
elution, they used 100% A to 70% A linear gradient. For MS/MS API 3000 with ESI was 
used in positive ion mode. The following transitions were monitored: +691/152, +691/135 
and +691/248 (for confirmation). As a result, method is capable of detecting c-di-GMP in low 
ng/ml concentration and perfectly works at 2 – 8 µg/ml range. All the fragments where 
important in order to distinguish from interferences. For internal standard cXMP (cyclic 
xanthine monophosphate) was used.  
Alternatively, Walker and Berkowitz (2013) proposed a method, which was able to 
separate most of known interfering compounds (including open cycle analogs) already by 
chromatography. This method was found to be suitable for both c-di-GMP and c-di-AMP. 
During bacteria growing, they performed the extraction steps two times (second time without 
hitting to 95°C (for proteins denaturation) with cooling in between for 20 minutes to 4°C, 
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while previous study suggested 1 time. By doing this, they got rid of most of the protein 
fragments and made the sample suitable for storing without losses at -20°C. Here they used 
acetonitrile for the eluent B. They also showed decrease in retention time without separation 
loss in HPLC. For IS 
15
N
13
C-c-di-GMP was used. 
In addition, method for LC/Q-TOF was also developed. It was used as a control for the 
riboswitch-based assay, described previously by Zhou et al. (2016). For HPLC they used 
Agilent™ C18 reversed-phase column (specific name not given) with isocratic elution (98% 
of water (with 0.2% of ammonium acetate and 0.1% of acetic acid) and 2% of methanol). For 
MS measurement, they used scanning mode with range m/z 100 to 1000 with scan rate of 2 
spectra per second. Even with all the simplicity of method, authors were able to get accurate 
results. 
As far, as research on c-GMP-AMP is only in the early phase, most of the authors use 
qualitative approach and much less precise instruments, like in the research on the structure of 
c-GAMP (Gao et al. 2015). Scientists used simple system of HPLC coupled with single 
quadrupole mass spectrometer. The eluents were water (with 10mM ammonium acetate and 
0.1% acetic acid) and acetonitrile. They report the elution of the compound between 20 and 
30% of acetonitrile (column – ODS-3 C18). In MS specific predicted mass was used (-673). 
They showed, that the 3`3` standard substance elutes later and only compound with same 
mass and retention time eluted from biological samples and protein assays. 
Concerning modifications, which were used for research on each of the CDNs, a 
question of creation of a ubiquitous method for all combinations of nucleobases arises. For 
solving this question, one should first find these compounds in nature and synthesize them as 
pure as possible.  
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2. MATERIALS AND METHODS 
2.1.  Synthetic c-di-NMP and their properties 
Main material, used for the investigation, c-di-NMPs (or CDNs), are compounds, which 
have a structure of two nucleotides, symmetrically or asymmetrically linked by their 
phosphate groups to ribose. In their turn, nucleotides incorporate a molecule of sugar (in 
nature ribose or 2-deoxy-D-ribose), phosphate groups, linked to its fifth carbon and a so-
called nucleobase, which is linked to its first carbon. The nucleobases are specific 
heterocyclic compounds that belong to either purines or pyrimidines. Natural known bases are 
shown in Figure 4. Adenine, guanine and cytosine are main components of RNA and DNA, 
while uracil is specific for RNA and thymine is DNA component. Other bases are really 
found in specific RNAs, except for inosine and xanthine, which are precursors of adenine and 
guanine. Normally, nucleotides are connected via singular bond between ribose hydroxyl 
group, connected to third carbon and phosphate at fifth carbon position. In such manner the 
linear polymers are formed. However, in case of dinucleotides, both phosphate groups of two-
nucleotide molecules attack hydroxyl of each other and such way form cyclic structure. That 
is the process, that happens during two steps protein-mediated reaction (Hyodo and 
Hayakawa 2008; Walker and Berkowitz 2013). 
 
Figure 4. Natural nucleobase residues: adenine, guanine, hypoxanthine, xanthine, theophylline, thymine, 
uracil, cytosine. Most of these compounds in nature have different modifications for specific purposes 
(Clivio et al. 2013) 
In organic synthesis, there are different strategies of forming such compounds. The 
most used are the following three (depending on initial compound): free nucleotide (Hyodo 
and Hayakawa 2008) or nucleoside-containing compound, for instance isobutyryl-TBS-
protected nucleoside phosphate (Gaffney et al. 2010) or nucleoside phosphoramidite 
(Hayakawa et al. 2003). Compounds synthesis for our experiment was based on second 
variant, as the easiest; however, the initial compound was not protected. It incorporated eight 
synthesis steps and two purification steps. Another difference from mentioned method is that 
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HPLC was used for last step, instead of crystallization to avoid possible degradation of 
obtained compounds, as their properties could differ from those of known compounds. For 
each of the compounds NMR spectra were acquired to check the purity and confirm the 
structure of synthesis products. All of them showed no significant impurities and had 
structural peaks, as predicted (data not shown). 
All the ten compound properties were examined. The compounds were found to be 
stable under broad range of pH (2.3-8.5) and relatively stable in water (40% degradation of c-
di-CMP after 12 hours at room temperature). Novel compounds did not show the ability to 
form oligomeric structures, like was shown for c-di-GMP, except possibly c-di-CMP.  
2.2. Laboratory equipment and reagents 
As all stages of experiment were carried out in one lab, we had all the tools and reagents 
necessary for them.  
Instruments: 
- Chemistry-HYBRID pump RC 6™ coupled with Bachofer vacuum concentrator 
centrifuge (Vacuumbrand
®
, Wertheim, Germany) 
- Ecotron™ shaker (Infors AG, Bottmingen, Switzerland) 
- Centrifuge 5427 R (Eppendorf®, Hamburg, Germany) 
- Centrifuge 5810 R (Eppendorf®, Hamburg, Germany) 
- Vortex™ mixer (VWR International bvba, Leuven, Belgium) 
- Heraeus Biofuge Pico™ (Kendro®, Hanau, Germany) 
- Branson® Sonifier SFX250™ (Emerson Electric Co., St. Louis, US) 
- Liquid chromatography unit including SPD-20A™, DGU-20A™, 2 LC-20AT™, 
CBM-20A™ (SHIMADZU®, Kyoto, Japan)  
- Mass spectrometer LCMS-2020 (SHIMADZU®, Kyoto, Japan) with ESI interface 
- Column heater THERMASPHERE™ TS-130 (Phenomenex®, Torrance, US) 
Tools: 
- MICROLITER™ syringes 10 and 25 µl (Hamilton Bonaduz AG, Bonaduz, 
Switzerland) 
- 0.2, 20, 200 and 1000 µl Pipettes (Eppendorf®, Hamburg, Germany) 
- 1.5, 2.0 and 0.5 tubes (Eppendorf®, Hamburg, Germany) 
Reagents and buffer components: 
- Acetonitrile HiPerSolv CHROMANORM™ (VWR CHEMICALS®, Fontenay-
sous-Bois, France) 
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- Ammonium formate HiPerSolv CHROMANORM™ (VWR CHEMICALS®, 
Fontenay-sous-Bois, France) 
- Formic acid Optima™ LC/MC (Fisher Chemical®, Illkirch-Graffenstaden, France) 
- Water, purified with Milli-Q Direct 8 system with 0.22 µm Millipak Express 40 
Final Filter (Millipore SAS, France) 
Other compounds were of analytical purity grade. 
2.3.  Culture growing 
The main focus was put on Escherichia coli, ssp K-12 variants (MG1655, BW). These 
strains are interesting in the point, that MG1655 preserves very high amount of genetic 
material richness and this makes it the closest to E. coli WT (wild type). Second variant, 
BW25113 has one of the richest gene knockdown collection, including part of the genes of 
interest (of DGC-candidates and CDN PDE-candidates families) (Baba et al. 2006). This 
bacterium was chosen not only because of its well-studied proteome and genome as a model 
organism, but also because it is shown to have ability for c-di-GMP production, while induced 
for biofilm formation (Caly and Bellini 2015; Krasteva et al. 2012).  
Besides model organisms (E. coli for gram-negative and B. subtilis for gram-positive), 
we used other bacteria species, which were reported to produce either c-di-AMP or c-di-
GMP. To check, whether test medium can bring artifacts, we used eukaryotic yeast species (S. 
cerevisiae). All the data about organisms, used for the experiment, are in table 1. We were not 
able to check the most known producer of c-GMP-AMP, Vibrio cholerae as the lab does not 
have permission to work with hazardous species.  
 
Table 1. List of organisms, reported to have CDNs 
Bacterium name Strain 
Growing 
media 
Known 
CDNs 
Reference 
Escherichia coli 
K-12 MG1655 
K-12 BW25113 
LB, M9 c-di-GMP (Romling et al. 2013) 
Bacillus subtilis DSM10 LB, MSgg c-di-AMP (Romling 2008) 
Saccharopolyspora 
erythraea 
ATCC 11635 
Medium 
65 
c-di-GMP (Krasteva et al. 2012) 
Staphylococcus 
cohnii 
GH137 LB c-di-GMP (Romling et al. 2013) 
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Bacterium name Strain 
Growing 
media 
Known 
CDNs 
Reference 
Comamonas 
testosteroni 
KF-1 LB c-di-GMP 
(Francis and Corbin 
1999) 
Pseudomonas 
putida 
KT-2440 LB c-di-GMP (Zogaj et al. 2001) 
Caulobacter 
crescentus 
CB15N PYE c-di-GMP (Spangler et al. 2010) 
Xanthomonas 
campestris 
ATCC 33913 
Medium 
54, TY 
c-di-GMP, 
possibly c-di-
AMP 
(Hyodo and Hayakawa 
2008; Huynh and 
Woodward 2016) 
Saccharomyces 
cerevisiae 
BY4741 YPAD -  
Generally, the procedure of growing was as follows: bacteria were inoculated in 
corresponding nutritious medium and left to grow for time, approximately meeting the needed 
living cycle phase (during the process each hour the optical density at 600 nm was measured 
until it reached correct level for the phase).  
2.4. Sample preparation 
After reaching desired OD, sample was separated in several (usually 5) portions and 
processed, using the following protocol, based on (Spangler et al. 2010) with significant 
modifications, therefore all the steps are shown: 
I. Centrifugation (4°C, 30 min, 1700 × g1)  
II. Resuspension and wash of each pellet with 5 ml phosphate buffer (pH = 7.4) and 
combining in one tube 
III. Centrifugation (4°C, 30 min, 1700 × g) 
IV. Resuspension of pellet in 6 ml H2O (Milli-Q) 
V. Lysis of cells by sonication (50% of maximum power, 6 min.) 
VI. Sample for Bradford assay (200 µl) 
VII. Transfer to 15 ml tube and addition of approximately equal volume of cold (4°C) 
acetonitrile  
VIII. Centrifugation (4°C, 30 min, 1700 × g) 
IX. Discarding pellet and freezing supernatant (in 2 ml Eppendorf tubes) 
                                                 
1
 G corresponds to standard acceleration due to gravity and equals to 9.81 m/s
2 
For composition of media – see annex A 
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X. Volume reduction by freeze-drying (approx. 1.2 h) 
XI. Centrifugation (4°C, 30 min, 21380 × g) 
XII. Transfer to “cut-off” filters 
XIII. Centrifugation (4°C, 30 min, 1700 × g)  
XIV. Complete freeze-drying (8-12 hours) 
These steps could be separated in groups: bacteria processing (step I. to V.), sample 
nucleotides separation (VII. to X.) and final purification (XI. to XIII.). Lysis-connected steps 
(III. to V.) were usually repeated 2 times. Step VI. was done for more precise determination 
of amount of the bacteria, as OD600 can give only very approximate information due to 
various possible effects, including contamination. Next steps were performed to separate 
liquid fraction of small molecules from cell debris and big proteins, remaining in liquid phase. 
In final part is another purification, performed with specific filter, which is capable to clarify 
sample from most macromolecules, which could remain in the sample. For this, so-called 
“cut-off” filter is used. Such filter consists of two main parts: the tube (usually 15 or 50 ml 
with specific cap) and the filter, which is placed inside the tube, in its upper part. The filter is 
a membrane with pores of specific size, which is measured correspondently to smallest mass 
(in Daltons (Da) – 1 Da ≈ (1.66 x 10-27) kg) of protein that can pass through it. For this step 
we used filter with the smallest pore size available on market (3 kDa, SIGMA-ALDRICH
®
), 
that roughly corresponds to 200 amino acids protein. The sample is transferred inside this 
filter and then centrifuged. We performed this step 2 times. Upon completing this procedure, 
sample was completely dried by lyophilization and then one of the Eppendorf tubes, 
containing sample was use for LC-preseparation 
2.5.  LC/MS parameters and solutions 
The central part of experiment was the separation and detection of 10 synthetic CDNs 
with the help of liquid chromatography-mass spectrometry. 
To have better and more stable method, we used system of two columns (“2D-HPLC”), 
first of which was used to collect the entire dinucleotides fraction, separately from other 
components. To achieve this, we choose Clarity™ Oligo-RP column (PHENOMENEX®) 
with precolumn. The column is designed to distinguish between oligonucleotides with even 
single base change, as well as between single and double stranded (ssDNA/RNA and 
dsDNA/RNA) in high concentrations of acetonitrile. We used relatively high aquatic 
conditions (88% at the elution) to reduce such discrimination, but enhance differentiation 
between compounds with different amount of nucleobases (especially cyclic 
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mononucleotides, which can affect separation on following columns). In addition, such 
purification allowed to separate CDNs from most of other compounds and, therefore, 
prolonged functioning and enhance separation (Fig. 5). 
For the separation of nucleobases, two columns were used. Main routine measurements 
were carried out, using C18 GravitySB™ (NUCLEODUR®) with particle size of 3 µm 
(MACHEREY-NAGEL GmbH & Co. KG 2015). The column is based on standard C18 with 
octadecyl modification and extensive endcaping. Such design should let the column to be able 
to distinguish among early-eluting polar compounds with close properties, including 
nucleotides, however it is not good in distinguishing differences among rotational or other 
steric isomers (Fig. 5). 
Second column was used for confirmation of new compound presence in sample. This 
column (C18 Isis™, NUCLEODUR®), also with 3 µm particles, is highly enriched with 
cross-linking and specific polymeric modifications (MACHEREY-NAGEL GmbH & Co. 
KG. 2015). Such modification gives to column good distinguishing properties towards the 
different steric isomers with same atomic composition. Using both of the columns, we 
suppose to see with high probability only the peaks, which correspond either CDNs or their 
products and not the linear dimers (product of RNA and CDNs partial degradation). 
 
To perform the LC steps, all the time the same eluents were used (for purification and 
for LC-MS measurement). We used system of two buffers of the following content: 
- Buffer A – H2O (Milli-Q™), with addition 0.1% formic acid and 10 mM 
ammonium formate; 
A B 
Figure 5. Tanaka plots of C18 Isis (A) and C18 Gravity-SB (B). The difference between properties of the 
columns give much more narrow range of possible compounds, which can elute simultaneously with target 
species (MACHEREY-NAGEL GmbH & Co. KG 2015; MACHEREY-NAGEL GmbH & Co. KG. 2015) 
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- Buffer B – acetonitrile with addition of 0.1% formic acid. 
All columns were stored with same storing solution, consisting of 80% of acetonitrile 
and 20% of water (Milli-Q). Before the measurements, each column was flushed with 
working buffers and time program was performed twice – firstly, without adding any sample 
and secondly with adding of 10 synthetic CDNs. Once a week both analytical columns were 
checked to have the same pressure at parameters as shown in their certificates. After using, all 
of the columns were washed with the initial solution for 10 column volumes. 
Most of the liquid chromatography parameters differ during the use of above-mentioned 
columns. For Clarity column, the injection volume was 20 µl (that represents 20 ml of initial 
culture) and the flow rate was constantly kept on 3.5 ml per minute. Pressure was controlled 
not to exceed 140 bars. No temperature control was used. Program started with 0% of B till 
1.5 minutes, followed by gradient till 1.6 minute to 12% of B with isocratic elution till 4.5 
minutes. Re-equilibration of the column was achieved by washing with 95% of buffer B from 
5 till 7 minutes. The detection was carried out by UV-detector at wavelength 260 nm and 
sampling rate – 2 Hz. Fraction of dinucleotides was collected and completely freeze-dried. 
After finishing lyophilization, 20 µl of buffer A were added to the sample. For analysis 
with C18 GravitySB and C18 Isis columns, 1 to 4 µl (representing 1 to 4 ml of bacteria 
culture) of sample were injected per run, depending on whether the sample was previously 
purified with Clarity column and on total current spectrum after first injection of 2 µl -. For 
C18 GravitySB, the flow rate was 0.3 ml/min, temperature was fixed to be 30°C, and the 
pressure was visually controlled not to be higher than 200 bars. As in previous method, time 
program started from 0% of B with rapid jump to 4% at 0.1 min, followed by two step 
slowing of gradient: to 6% at 2 minutes and to 8% at 5 minutes. The wash with 95% B from 7 
till 12 minutes was performed to refine the column properties and wash out all the 
contaminating compounds of the sample. 
For C18 Isis column flow rate was 0.2 ml/min and temperature of 30°C, pressure not 
exceeding 180 bars. Program started at 0% of buffer B, quickly raised to 4% at 0.1 min and 
had 3 linear gradient parts: 4% to 6% at 2 minutes, 6% till 7% at 4 minutes and 7% till 20% at 
9 minutes with column wash till 18 minutes at 95% of B. In both of latter and the previous 
programs, when measuring biological sample combination of 10 synthetic CDNs in 
concentration of 5mM of each was used for spiking the samples. These compounds were 
added in either 1 or 2 µl of solution. After performing the program 2 to 4 minutes were let for 
the column to return to initial pressure values (174 bars for C18 GravitySB and 169 bars for 
C18 Isis) 
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Mass spectrometer was used only with the two latter columns and was coupled with 
HPLC system via ESI interface. Drying and colliding gases were N2 at 8 and 1.5 L/min 
respectively. Interface and heat block temperatures were set to 250°C and 200°C respectively. 
Detector voltage was 1300 V, vacuum – 4.8·10-4 Pa. Preliminary measurements were 
performed in scan mode, while actual analysis – in SIM mode for higher signal/noise ratio. 
Both Negative and positive ionizations were performed 
For samples, separated with C18 GravitySB, actual recording of mass spectra was 
performed from 3 to 6 minutes and by C18 Isis – from 5.5 till 10.5 minutes. 
2.6.  Data treatment and processing 
All of the measurements and data processing were performed using standard tool – 
Shimadzu LabSolutions™, which contains applications for HPLC and LC-MS experiment 
performing, as well as tools for viewing spectra and peaks’ manipulation (“Browser” and 
“Postrun”). Most of the spectra area and height data were acquired in automatic mode with 
following parameters (separately for each m/z value): maximum of peaks – 20, slope – 1200/s 
(for c-di-CMP – 700/s), broadness – 0.07 min. In cases of obvious peak overlap or bigger 
peak observed in the sample (particularly for c-di-UMP), manual modifications were made. 
All the calculations and graphical material preparation were performed using Microsoft
©
 
Excel™ 2016. 
Calibration curve was built for the reasonable range of 1.25 to 25 mM. Stability and 
reproducibility estimated on basis of measurements of standard mixture over 4 months for 
C18 GravitySB and about two months for C18 Isis.  
Reproducibility evaluations contained 11 measurements for Isis and 31 for GravitySB, 
performed at different days at the same conditions and from the same set of standard 
compounds. Measurement with C18 GravitySB started from late February and for C18 Isis – 
beginning of April 2016. 
Each of the biological samples was measured in two duplicates – twice only sample and 
twice a mixture of same amount of sample with standard. For repeatability, samples from two 
independent cultures were measured. Values were calculated on basis of mean of all four 
same measurements, while standard deviation – on basis of averages of two independent 
measurements. Calculation of approximate concentration were performed on basis of relation 
of sample value-to-value of sample plus standard. Finally, results were given in nM and ng/ml 
of CDNs in initial volume, normalized to OD600 of culture just before sonication.  
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3.  RESULTS AND DISCUSSION 
3.1.  Method performance  
In this section, data of the method optimization and control are presented. As the use of 
synthetic standards was throughout the whole experiment, all the methods were optimized for 
best separation of these compounds.  
3.1.1. Purification 
Separation of the dinucleotide fraction from other compounds, active at 260 nm 
wavelength, was performed at the 12% of acetonitrile phase of the chromatographic program. 
For testing, mixture of CDNs was spiked with 20 µM of mononucleotide Adenine (Sigma-
Aldrich, Hungary) and nucleotide oligomers (Glen Research, US). This is shown on the 
Figure 6. 
 
Method was optimized to be highly stable in the elution times even without temperature 
control, with the fraction collected from 2.75 till 3.35 minutes (deviation less than 0.025 
minute), which corresponds to approximately 2 ml eluent solution with compounds. 
Although, peak did not have symmetric shape and had tailing (Fig. 7.), it was sufficient for 
such purification. For standard, the peak height was around 4000-5000 intensity units.  
Unfortunately, this method does not allow collecting full fraction of c-di-CMP, which 
was eluted earlier (2.6-2.65 minutes) and only around 30% remain in the main fraction. Such 
behavior suggests impurities and possible degradation of the compound.  
 
O M 
O M 
Figure 6. Spiking of standard for Clarity Oligo-RP purification test. First chromatogram corresponds to 
non-spiked sample, while second is spiked. O – oligonucleotides, M – adenosine monophosphate. Dashed 
line directs to unknown peak, which may be impurity in commercial oligomer or result of formation of 
short double strands of RNA. Numbers correspond to peak areas Part after 2.8 minutes is removed 
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 After such purification, in combination separation with 0.22 µm filter, bacterial extracts 
were pure enough to observe changes at nanogram per milliliter level, in the positions 
corresponding to standards’ retention time. 
3.1.2. Separation of cyclic dinucleotides with different C18 columns  
Columns used for LC-MS analysis, showed differences both in the order of the 
compounds elution and in overall retention time. In the beginning, samples were also 
measured without purification procedure for additional testing. Later it was abandoned, due to 
high column damage as one of the C18 GravitySB columns was destroyed. To stabilize 
retention time, columns were kept in the column heater at stable temperature 30°C. C18 Isis 
showed to have better retention time stability (Table 2) and higher distinguishing ability for c-
AMP-CMP, however peak shape was much worse, as with C18 GravitySB and did not change 
much with significant changes to the gradient.  
Both columns had their beneficial properties: the C18 Isis has better resolution and 
peaks’ retention time fluctuates much less and C18 GravitySB had better peaks shape and re-
equilibrates faster, so more suitable for quantification and every-day use. Still, both columns 
give artifacts, which can be rejected only by measuring sample on both of them. 
All the CMP-containing compounds show to have an additional peak, coupled closely 
with the main one on C18 Isis. This is possibly due to synthesis non-selectivity, causing 
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Figure 7. Chromatogram of standard during the purification. Most of the 260 nm- active compounds 
were eluting in the 12% acetonitrile, except for a minor peak, eluting just after the collected fraction. 
Numbers correspond to peak area. Part from 4.5 till 7 minutes is removed for better visualization; no 
peaks occurred in it. 
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standard to be a mixture of several CDN optical isomers or spontaneous transition between 
isomers in the mixture, though the NMR tests did not show it for most of the compounds and 
only slightly for c-di-CMP. 
We decided to calculate the approximate amount only using C18 Gravity SB column 
and confirm the possible peaks using C18 Isis. 
 
Table 2. Cyclic dinucleotides properties 
To estimate lowest possible concentration and the linearity of method, calibration 
curves (Fig. 8) were built separately for each compound (annex C). The lowest linear amount 
was 2.5 nM (≈ 1.5 ng/ml) and method remained linear till 25 nM (≈15 ng/ml). These 
concentrations are lower, than in previously suggested method (Walker and Berkowitz 2013; 
Spangler et al. 2010). However, to calculate higher concentrations of CDNs, mentioned 
methods are recommended. 
Name of 
compound 
Mass, Da 
Retention time 
C18 GSB, min 
Peak shape 
C18 GSB 
Retention time 
C18 Isis, min 
Peak shape 
C18 Isis 
c-di-CMP ≈610 3.79 ± 0.09 Broad, fronting 6.15 ± 0.1 
Very broad, 
strong tailing 
c-CUMP ≈611 3.83 ± 0.04 Good 7.75 ± 0.02 
Good, minor 
tailing 
c-di-UMP ≈612 4.16 ± 0.19 
Good, two 
major peaks 
9.64 ± 0.01 Broad 
c-CAMP ≈634 3.92 ± 0.19 
Good, minor 
fronting 
7.66 ± 0.03 Strong tailing 
c-UAMP ≈635 3.96 ± 0.12 Good 8.86 ± 0.02 Good, tailing 
c-CGMP ≈650 3.94 ± 0.19 Good 7.81 ± 0.03 Strong tailing 
c-UGMP ≈651 4.13 ± 0.19 Good 9.42 ± 0.02 Tailing 
c-di-AMP 658.412 4.12 ± 0.17 
Broad, minor 
fronting 
8.67 ± 0.04 
Tailing, minor 
broadening 
c-AGMP 672.395 4.1 ± 0.22 Good 8.93 ± 0.04 Good, tailing 
c-di-GMP 690.411 4.29 ± 0.22 Good 9.35 ± 0.05 Tailing 
Approximate masses here are of the compounds, which were not found in nature. During analysis 
with mass spectrometer, their m/z ratio was set as x.15, where x – mass from the table. 
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Use of probes with lower concentrations appeared to have non-linear relationship of 
signal and the concentration was not estimated at that levels. As to qualitative amounts, the 
LOD in E. coli for samples each compound was between 0.12 and 0.02 ng/ml for C18 
GravitySB and 0.05 to 0.01 ng/ml for C18 Isis. The only exception was c-di-CMP with 
respective values of 0.23 and 1.091 ng/ml that is due to the high losses of this compound 
during the LC purification. For detailed data – see annex B. As we put use both columns, 
overall limit for most compounds is of GravitySB and for c-di-CMP is the one of Isis.  
 Reproducibility (Fig. 9) on both columns is within 15% level (except of c-di-UMP on 
C18 GravitySB, which had 19.9%), and the fact, that first and last measurement difference is 
small (see annex D) that suggest that all samples, measured with the method remain 
comparable and the method has low short-time bias. Greater difference in c-di-UMP is due to 
the two peaks of the standard on GravitySB. This suggests that synthetic compound is the 
mixture of isomers with different hydrogen bonging properties, but not sterically different 
(one peak on Isis). 
Measurements of synthetic standards were found not to be interfering with various 
known compounds of nucleotide nature, including various polyphosphate compounds, linear 
dinucleotides and cyclic mononucleotides. All of these compounds have different retention 
times either during Clarity Oligo-RP purification or during LC-MS separation and analysis 
with C18 GravitySB/Isis. 
Figure 8. Calibration curve of the standard substances (on example of c-AMP-CMP) using C18 
GravitySB. For lower concentrations, error bars are hidden being points. 
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3.1.3. Results of mass spectrometric analysis 
Ionization of compounds was performed in both positive and negative mode (under 
standard parameters for measuring). Signals in negative mode were more distinct and had 
better isotope profile (Table 3). This data was achieved from a direct comparison of average 
intensity of mass-ions in positive and negative modes. 
 In positive mode, nevertheless, was only one peak for c-di-UMP, instead of two in 
negative, when working with C18 GravitySB. On C18 Isis column negative mode gave only 1 
major peak and 2 to 3 minor with intensity 4 or more times lower. 
 
Table 3. Ionization in positive and negative modes. 
Bases of CDN 
1 C C U C U C U A 
2 C U U A A G G A 
Ionization ratio 
pH 3 2 20 20 5 3 5 7 6 
pH 7 10 25 100 5 20 5 50 6 
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Reproducibility of Standards' area C18 Isis C18 GravitySB
Figure 9. Reproducibility of standard compounds signals on different columns: blue corresponds to C18 
GravitySB and yellow – C18 Isis. Error bards correspond to standard deviation of responses. Percentages 
below the Figure correspond to ratio between standard deviation and average area of above-mentioned 
molecule of standard mixture. 
C18 GSB 13.5% 13.3% 19.5% 11.2% 10.9% 9.8% 11.1% 14.9% 12.0% 12.8% 
C18 Isis 9.7% 6.1% 7.8% 6.6% 7.3% 5.7% 4.1% 7.1% 6.2% 7.9% 
 
Numbers here show, how much bigger the peak of the same compound is in negative mode, than 
positive. 
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Another problematic point with negative mode was appearance of doubly charged ions, 
which greatly lowered the detection ability for respective nucleotides (Fig. 10). This was most 
significant for c-di-CMP and at much lower level with other CMP-containing compounds. 
Throughout all of the analytical steps in the method, we were experiencing difficulties 
with c-di-CMP standard and possible candidates for it. This compound showed distinct 
properties from the rest and we were not able to incorporate fully it in the overall method. 
Easier double charging of c-di-CMP suggests, that this compound is either not purely 
synthesized, as was mentioned previously, or has distinct properties from other cyclic 
compounds, that does not clearly come from the structure. Latter may be, for instance, same 
constructs, as of c-di-GMP (Fig. 2) or another form of stacking, and is stronger, comparing to 
other compounds, and so effecting ionization. Another explanation would be that the 
compound is not stable and quickly degrades. But this is not deducible from the structural 
point of view. 
3.2. Analysis of bacterial samples 
The procedure, outlined in section 2.4. was applied to all the bacterial samples. The 
most crucial in terms of sample losses was bacteria destruction by sonication. Up to 50% of 
bacterial culture sample volume was lost during this procedure. However, passing standards 
though the whole sample preparation procedure did not show the significant difference in 
amount of compounds, suggesting, that neither of steps influence the compounds. This, 
nevertheless, may be different for compounds in cells, as they may be bound to some proteins, 
especially transmembrane, and be later stacked in cell debris. Therefore, this step needs 
significant optimization, when transferring to quantitative analysis.  
Figure 10. Fragment of mass spectrum in SCAN mode. Peak 609.14 corresponds to singly charged c-di-
CMP and 304.08 – doubly charged 
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Samples of bacterial extracts were measured without the bacteria name label (blind 
measurement). In the MS chromatograms were several big peaks in the same m/z ratio as 
compound, but they were not masking the regions of standards’ and proposed candidates’ 
elution.  
 
Table 4. CDNs presence in various bacteria 
Code Organism Phase 
c-
d
i-
C
M
P
 
c-
C
U
M
P
 
c-
d
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U
M
P
 
c-
A
C
M
P
 
c-
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P
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G
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P
 
c-
G
U
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c-
d
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A
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A
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P
 
c-
d
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G
M
P
 
#15a St. cohnii exp 
  
yes yes 
      
#15b St. cohnii stat 
   
yes 
      
#17a C. testosteroni exp 
 
yes 
 
yes 
   
yes 
 
yes 
#17b C. testosteroni stat 
          
#18a Ps. putida exp 
      
yes 
   
#18b Ps. putida stat 
         
yes 
#4b B. subtilis exp yes 
  
2.77 
      
#4c B. subtilis stat yes 
         
#4d B. subtilis film 4.52 
 
2.8 yes 
   
yes 
  
#14a S. erythraea exp 
  
11.48 
  
yes 
   
yes 
#14b S. erythraea stat 
          
#16a S. cerevisiae exp 
   
yes 
     
yes 
#16b S. cerevisiae stat 
          
#19a C. crescentus exp 
  
4.84 yes 
     
yes 
#19b C. crescentus stat 
  
3.41 
       
#20a X. campestris exp 
 
2.84 
 
yes yes 3.8 yes yes 
 
yes 
#20b X. campestris stat 
     
yes 2.9 
 
yes 
 
#20c X. campestris exp 
   
yes 
  
3.45 yes yes 
 
#20d X. campestris stat 
      
3.17 yes yes 
 
All the found compounds’ signals are referred as candidates. All the values represent the amount, 
measured with GravitySB (mean of two repeats of two independent cultures). If measured quantity 
was below the lowest of calibration points, but still clearly distinguishable, label “yes” was used to 
signify its presence. 
Exp in this table stands for middle period of exponential growth phase and corresponds 3-5 hours of 
growing, Stat - stationary phase of bacterial growth and corresponds to overnight culture and film - 
biofilm growth, that was collected approximately after 10 hours of growing. 
All the bacteria were grow on one medium, except of X. campestries and B. subtilis. First was in 
parallel on two media – samples 20a and 20b on medium 54 and 20c and 20d – TY-medium. Second 
was grown on specific medium to induce biofilm formation. 
All the concentrations are given in nM 
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Table 4 shows the data on all the various bacterial extracts measured to test method. 
The compounds, which were found on one column, but not on both are not included (see 
annex E). We found, that we are able to detect all the previously identified compounds in 
different species at least in one stage of growth. The only exception was Staphylococcus 
cohnii, which we were no able to grow to high OD600 and latter attempts were not successful. 
Beneficial decision was the usage of two columns for confirmation of the peak of the 
compound of interest. Measuring with a single column the purified sample did not give 
enough confidence, as in most samples there were non-reproducible peaks in independent 
cultures repeats. 
 Comparing, for instance data for E. coli, we were able to reject many peaks, which 
were not eluting at the same time, as standard (especially c-AMP-CMP candidate) on one of 
the columns.  
Nature of the non-reproducible peaks, could be explained in many ways, but the most 
probable suggestions were artifacts from medium or differences in culture preparation 
(growing period, inappropriate medium preparation), since they were prepared not in the same 
time, but with several weeks difference.  
To estimate losses and matrix effects in the LC-MS procedure, we took the ratio of 
average of difference between spiked and non-spiked samples to the average of standard 
(table 5) Results, show that various CDNs are affected differently, however, many of them 
have recovery around 85%. On the other hand, deviation of some sample peaks of compounds 
was up to 40% (c-di-AMP); this can be seen in table 5. 
 
Table 5. Sample loss during the process of measurement on C18 GrasitySB 
Name of 
compound 
Direct standards’ 
average 
Samples, spiked with standards 
Recovery 
Average Deviation 
c-di-CMP 20444.73 15559.67 33.83% 76.11% 
c-CUMP 44774.48 25921.67 2.84% 57.89% 
c-di-UMP 64785.68 49413.00 28.81% 76.27% 
c-CAMP 119151.71 78912.60 30.03% 66.23% 
c-UAMP 171394.13 151307.00 23.40% 88.28% 
c-CGMP 72385.50 64705.14 17.16% 89.39% 
c-UGMP 205552.77 159472.75 20.43% 77.58% 
c-di-AMP 152720.92 128118.93 39.31% 83.89% 
c-GAMP 262913.65 215556.67 26.84% 81.99% 
c-di-GMP 180203.77 155394.40 15.92% 86.23% 
 
27 
 
Finally, E. coli, was sampled at different phases of growing to test the hypothesis, that 
the production of CDNs may be dependent from bacteria growing stage. We prepared four 
samples, which should correspond to different points on the growing curve, labeled: early 
exponential (2-3 hours after inoculation), middle exponential (4-5 hours), late exponential (5-
8 hours) and stationary (more than 8 hours after inoculation). Results could be seen in table 6. 
 
Table 6. Growth-phase emerging of CDNs 
E. coli variant MG 1655 BW 25113 
Phase exp early 
exp 
middle 
exp late Stat exp early 
exp 
middle 
exp late stat 
c-di-CMP         
c-CUMP         
c-di-UMP         
c-ACMP         
c-AUMP         
c-CGMP         
c-GUMP         
c-di-AMP         
c-AGMP         
c-di-GMP         
To control the influence of the medium on the response, salt-based medium M9 was 
used. This medium does not contain any of the biological extracts, like yeast extract in LB 
(see Annex A), therefore no medium effects on the signal are possible. In addition to c-di-
GMP, we were able to confirm presence of c-AMP-CMP (1.08 ng/ml in middle exponential 
phase and 0.47 ng/ml in stationary), c-GMP-UMP (0.83 ng/ml in middle exponential phase) 
and c-GMP-CMP (0.29 ng/ml in stationary phase) candidates on it, as well as their 
dependence on stage of growing. This shows that the compounds come from the bacteria and 
not from the medium. However, c-CMP-UMP seems to come from the LB medium or is not 
produced in the used conditions. 
Possible discovery of the cyclic dinucleotides, other than currently known, suggests that 
these compounds have even more diverse functions, than those confirmed. They may emerge 
as real analogs of complex secondary messengers’ regulatory system in plants and animals, 
influencing all parts of bacterial life. Moreover, such diversity fit with the fact of varied 
Colors represent relative amount of corresponding dinucleotide. Pastel red – very low (< 0.2 ng/ml), 
pastel yellow – low (0.2 to 0.7), pastel green – middle (0.7 to 1.5) and deep green – high (>1.5). All the 
levels are based on approximate values, normalized to OD600 of the bacterial cultures before 
processing. 
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metabolism and environment adaptation abilities and limited compartmentalization of 
prokaryotic cell. As the compound candidates were found in most of the samples, they could 
be ubiquitous in the diversification signal strategy of all the Prokaryota. 
Another important suggestion is the dependence of the amount of some of cyclic 
dinucleotides on certain phase of growing, while others were independent of it. If confirmed, 
this can be a key to search of the conditions and factors, which lead to the production of such 
compounds.  
Depending on biological function of the suggested molecules, the development of 
monitoring and the amount controlling methods could be beneficial for both medicine and 
biotechnology to have more advanced tools for metabolism manipulation of microorganisms 
and to overcome resistance against medicines.  
3.3. Further improvements 
Although, the developed method is already working, most steps of the it could be 
further optimized. 
Possible good addition in the purification steps is a column, which can separate by 
different amount of phosphorus in the compound, as it would discriminate polyphosphates 
already on this stage, making the sample purer for analytical separation, as well as it would 
serve as better confirmation of the group of compounds, that we are dealing with. 
The most crucial step to be taken in order to have confidence in the compounds’ 
candidates, is use of the LC-MS
N
 system. As was reported for discovered compound, there 
may be peak overlaps at specified m/z ratio before fragmentation (Spangler et al. 2010; 
Walker and Berkowitz 2013). Therefore, use of triple quadrupole or other tandem mass 
spectrometer for investigation of this issue is inevitable. 
As aim of the method was to preliminary identify various CDNs, we were optimizing it 
to be able to find each of the 10 synthetic compounds at the same time. This bring to the 
point, that the time program and the parameters may not be perfect for each individual 
compound, but rather the optimal to quick search for all of them in the biological sample. 
Therefore, further optimization for individual compounds may be necessary for lower LOD 
and better separation from possible interferents.  
The most problematic of all the compound is c-di-CMP. This compound elutes 
significantly earlier and, therefore, it is difficult to optimize the method to include it for even 
semi-quantification. Separate method, based on purpose would be a better alternative. 
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There are several steps to be optimized, in sample preparation before liquid 
chromatography separation. First of all, the cell destruction method should be either changed 
to lysis with lytic buffer with further salts removal, or fine tuning of sonication procedure. 
Another point in sample preparation part is estimation of growing phases of bacteria. These 
steps must be taken with stronger time precision (at least by hour instead of approximate 
phases period, taken from the literature). 
For better quantification, internal standard method could be used in addition to spiking. 
This would allow give high precision recovery information for the whole sample preparation 
procedure. In addition, establishing of high-specific method for quantification of bacteria in 
culture is preferable. The simplest of such methods is the protein assays, such as those after 
Bradford (Zheng et al. 2015) or after Smith (Bai et al. 2012). Currently, procedure after 
Bradford is being implemented and should be introduced before switching to tandem mass 
spectrometry and the part of each sample is already being taken for this assay. 
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CONCLUSION 
Cyclic dinucleotides, although known for a long time, received considerable attention 
only recently. These compounds play central role in various bacterial key processes from 
motility to triggering pathogenesis and also play role in mammalian response to the 
pathogens. They are synthesized and degraded by distinct group of proteins. Dinucleotide 
cyclases have high specificity towards not only nucleotides, but also positions of their 
cyclisation. Phosphodiesterases of cyclic dinucleotides besides degrading function, often play 
role of the intracellular receptor. 
Until now, only three compounds were found and confirmed in nature. However, many 
proteins with specific characteristic domains do not react on the discovered compounds in 
vitro. This fact suggests that there may be other compounds with close properties and the 
necessity of their discovery is undoubtable. 
The main goal of this research was to develop the method, which could be suitable to 
identify possible candidate compounds of cyclic dinucleotides in bacteria extracts by liquid 
chromatography - mass spectrometry. This goal was achieved with following results. 
Method development was based on the synthetic cyclic dinucleotide compounds, 
synthesized in-house. Sample preparation involved several purification steps and led to 
separation of dinucleotide fraction with low contamination by compounds with different 
properties and structure. 
For analysis, separation of standard was set to be performed by two C18 columns with 
different properties. GravitySB to use for everyday measurement and Isis for confirmation of 
findings in biological samples. Peaks were narrow (around 0.3 minutes), but only peaks on 
GravitySB were symmetrical. 
Method had limit of detection of 0.12 ng/ml or lower, depending on compound, with the 
exception of c-di-CMP, which was not possible to optimize for eluting with other compounds. 
Linear range on GravitySB was between 1.5 ng/ml and 15 ng/ml, which is sufficient for 
biological samples. Method was highly stable with standard deviation for standard 
compounds not exceeding 20% for GravitySB and only 9.7% at highest for Isis. 
For mass spectrometry, negative mode was chosen as it gave higher ionization of the 
target compounds. 
Analysis of biological samples revealed, that method is capable to confirm in most 
cases findings from literature, as well as candidates for some new compounds. It was also 
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shown, that some of this candidates change their abundance in growing phase-dependent 
manner. 
To confirm the findings, it is important to perform measurements on more refined mass 
spectrometer with fragmentation. 
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ANNEXES 
Annex A. Media composition 
LB medium 
1. Add the following to 800.0 ml H2O 
- Tryptone. 10.0 g 
- Yeast extract. 5.0 g 
- NaCl. 10.0 g 
2. Adjust pH to 7.5 with NaOH. 
3. Adjust volume to 1.0 l with dH2O 
4. Sterilize by autoclaving 
 
M9 medium 
1. Make M9 Salts: 
- aliquot 800.0 ml H2O 
- Na2HPO4×7 H2O 64.0 g 
- KH2PO4 15.0 g 
- NaCl 2.5 g 
- NH4Cl 5.0 g 
- Stir until dissolved 
- Adjust to 1000ml with distilled 
H2O 
- Sterilize by autoclaving 
2. Measure ~700.0 ml of distilled H2O 
(sterile) 
3. Add 200.0 ml of M9 salts 
4. Add 2.0 ml of 1 M MgSO4 (sterile) 
5. Add 20.0 ml of 20% glucose (or other 
carbon source) 
6. Add 100.0 µl of 1 M CaCl2 (sterile) 
7. Adjust to 1000 ml with distilled H2O 
 
MSgg medium 
1. 50.0 μM MnCl2 
2. 5.0 mM KH2PO4 
3. 1.0 μM ZnCl2 
4. 50.0 μM FeCl3 
5. 2.0 mM MgCl2 
6. 700.0 μM CaCl2 
7. 50.0 μg/ml threonine, tryptophan, and 
phenylalanine 
8. 0.5% glutamate 
9. 0.5% glycerol 
10. 2.0 μM thiamine 
11. 100.0 mM morpholinepropanesulfonic 
acid (MOPS) (pH 7) 
GYM Streptomyces medium (medium 65) 
 
1. Glucose 4.0 g  
2. Yeast extract 4.0 g  
3. Malt extract 10.0 g  
4. CaCO3 2.0 g  
5. Agar 12.0 g  
6. Distilled water 1000.0 ml 
7. Adjust pH to 7.2 before adding agar. 
Delete CaCO3 if liquid medium is used. 
 
PYE medium 
1. K2HPO4 1.00 g  
2. MgSO4 x 7 H2O 0.20 g  
3. CaCl x 2 H2O 0.02 g  
4. Na2S2O3 x 5 H2O 0.20 g  
5. Na-pyruvate 2.20 g  
6. Yeast extract 4.00 g  
7. (NH4)2SO4 1.00 g  
8. Trace element solution SL6 (see Medium 
27) 1.00 ml Distilled water  
9. 1000.00 ml 
10. Adjust pH to 6.8.  
11. Boil the medium for few minutes. Fill in 
tubes with rubber stoppers under nitrogen 
gas. Sterilize at 121°C for 15 min.  
 
Glucose yeast extract medium (medium 
54) 
1. Glucose 20.0 g 
2. Yeast extract 10.0 g 
3. CaCO3(light precipitate) 20.0 g 
4. Distilled water 1000.0 ml 
5. For solid medium, add 17.0 g/l agar. 
TY medium 
1. H2O 1 L 
2. Tryptone 6.0 g 
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3. Yeast extract 3.0 g 
4. CaCl2×2 H2O 0.5 g 
5. Agar-agar (optional) 12.0 g 
6. agar 3.0 g + broth per bottle 250.0 ml 
 
YPAD medium 
1. Yeast extract 1% 10.0 g 
2. Peptone 2% 20.0 g 
3. Glucose 2% 20.0 g 
4. Agar 2% 20.0 g 
5. Adenine sulfate 0.004% 40.0mg
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Annex B. Limit of detection 
C18 Isis 
E. coli Average St Dev LOD (µV) Standards Mr, Da LOD (ng/ml) CDN 
714 539 515 535 547 518 580 637 549 538 567.2 62.50 773.45 4564.82 610 1.034 c-di-CMP 
277 403 380 350 363 354 370 353 370 320 354 34.60 468.17 59514.82 611 0.048 c-CUMP 
415 323 320 293 330 315 343 320 312 333 330.4 32.61 438.00 52133.82 612 0.051 c-di-UMP 
293 341 369 328 369 332 399 414 440 380 366.5 44.26 512.57 130293.36 634 0.025 c-CAMP 
270 334 324 335 324 357 381 395 378 428 352.6 44.81 500.46 168624.18 635 0.019 c-UAMP 
436 279 463 323 395 378 359 415 338 322 370.8 57.40 560.22 117074.18 650 0.031 c-CGMP 
253 384 415 420 392 419 396 437 389 358 386.3 51.97 557.80 253986.55 651 0.014 c-UGMP 
637 154 202 173 193 210 199 228 237 235 246.8 139.62 707.55 198145.64 658 0.023 c-di-AMP 
634 986 860 1052 974 958 1013 960 993 1051 948.1 123.10 1354.32 353129.55 674 0.026 c-AGMP 
216 583 469 444 467 436 465 434 486 425 442.5 91.39 744.08 222148.91 690 0.023 c-di-GMP 
  
C18 GravitySB 
E. coli Average St Dev LOD (µV) Standards Mr, Da LOD (ng/ml) CDN 
433 247 446 428 284 472 499 546 463 514 433.2 96.09 750.29 20444.73 610 0.224 c-di-CMP 
544 437 392 333 388 457 363 441 499 354 420.8 67.24 642.69 44774.48 611 0.088 c-CUMP 
540 799 655 378 803 613 701 466 878 424 625.7 172.14 1193.77 64785.68 612 0.113 c-di-UMP 
476 447 306 299 320 401 306 438 476 514 398.3 83.30 673.18 119151.71 634 0.036 c-CAMP 
494 332 430 462 463 425 418 500 517 416 445.7 53.94 623.69 171394.13 635 0.023 c-UAMP 
605 278 506 334 456 407 419 399 366 394 416.4 91.01 716.74 72385.50 650 0.064 c-CGMP 
436 445 686 369 634 469 349 521 486 525 492.0 106.05 841.96 205552.77 651 0.027 c-UGMP 
705 556 376 553 407 539 584 396 519 524 515.9 99.89 845.53 152720.92 658 0.036 c-di-AMP 
394 656 575 279 647 557 371 561 625 480 514.5 128.75 939.36 262913.65 674 0.024 c-AGMP 
731 282 543 452 664 292 624 370 334 621 491.3 166.30 1040.10 180203.77 690 0.040 c-di-GMP 
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Annex C. Calibration curves prepared on C18 GravitySB column.  
For all the graphs: values on abscissa – concentration in ng/ml; on ordinate – intensity in µV 
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Annex D Standards’ reproducibility 
C18 Isis  
c-di-CMP c-CUMP c-di-UMP c-CAMP c-UAMP c-CGMP c-UGMP c-di-AMP c-AGMP c-di-GMP Compounds 
4580 59378 50753 132299 179749 108432 255837 189029 381151 238091 22.May 
4250 62928 52138 134006 175406 131394 249317 188369 361087 218071 19.May 
4858 60645 48397 141439 156945 125513 238376 192581 349766 217623 18.May 
4360 58442 46065 135664 172616 115278 261342 217580 326578 254856 17.May 
4608 62554 56831 123148 178986 110381 267603 201466 351193 218408 14.May 
4036 57192 53789 130611 165247 117928 259576 175687 332860 227048 06.May 
4525 63044 55961 135938 177915 117013 246282 207932 372289 211812 30.April 
5526 60800 55656 135937 166097 114873 250844 190712 312135 207409 21.April 
5047 53371 53314 124756 139102 112287 247274 194647 366600 208061 19.April 
4343 53236 45158 129576 165295 113876 272118 224655 354608 197518 13.April 
4080 63073 55410 109853 177508 120841 245283 196944 376158 244741 06.April 
4564.818 59514.82 52133.82 130293.4 168624.2 117074.2 253986.5 198145.6 353129.5 222148.9 average 
441.6976 3642.34 4066.27 8571.641 12227.58 6722.317 10288.18 14036.5 21773.86 17431.82 standard deviation 
9.68% 6.12% 7.80% 6.58% 7.25% 5.74% 4.05% 7.08% 6.17% 7.85% %stdev 
10.92% 6.22% 9.18% 16.97% 1.25% 11.44% 4.13% 4.19% 1.31% 2.79% %first/last 
C18 GravitSB 
c-di-CMP c-CUMP c-di-UMP c-CAMP c-UAMP c-CGMP c-UGMP c-di-AMP c-AGMP c-di-GMP Compounds 
17804 50307 65953 112653 185304 81073 194335 142730 254600 218428 23.May 
22444 45443 63884 109613 137961 74475 178219 145356 212154 169770 05.May 
18162 47464 56848 113671 164417 70695 229873 158476 222075 176214 04.May 
23975 56494 41672 116593 183533 70032 174711 147211 243843 193235 03.May 
25038 41165 62797 115359 166768 56314 216391 129186 248475 173264 02.May 
21518 34674 73491 119724 179453 76767 226730 155478 291387 197939 28.April 
23228 44288 54479 123450 186477 75505 212878 134947 241905 167943 27.April 
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c-di-CMP c-CUMP c-di-UMP c-CAMP c-UAMP c-CGMP c-UGMP c-di-AMP c-AGMP c-di-GMP Compounds 
19763 47733 65733 148911 187081 79583 188103 153099 268910 205763 26.April 
17147 50156 78429 128115 177889 67609 220415 176763 310916 203593 20.April 
23300 50110 50415 117835 205124 84359 209263 142322 295580 179777 18.April 
20168 44010 56642 112234 158076 73382 209261 161525 288388 190354 14.April 
20205 42845 74740 120512 178478 71923 227284 140482 246343 164743 11.April 
16556 45076 71880 113593 164198 75310 216974 151266 231543 176155 08.April 
22521 36014 53214 110940 153725 73508 200755 156339 262596 140423 07.April 
16771 48919 58912 127301 157099 69574 212152 150398 268966 154221 06.April 
19249 38879 81113 116809 208553 76970 217919 138443 310301 157007 05.April 
22324 50659 68311 120011 139382 61283 191406 149601 333441 175935 04.April 
26161 39498 78891 140322 165608 64052 241905 156333 273174 138682 01.April 
17342 48948 95996 144522 171971 71431 134592 251181 220250 145441 30.March 
19387 46990 60643 113567 177848 65654 213054 164903 281125 207222 16.March 
20055 43893 55945 117940 165583 71322 208930 152976 266137 191791 14.March 
23800 50195 58835 125495 180004 71870 225409 163509 292744 210587 11.March 
20836 51204 60066 118906 176971 68824 216934 159544 283698 206634 08.March 
17544 37597 57351 104713 154556 62329 182311 139311 233048 169694 07.March 
17947 38204 68918 103502 178430 76926 204180 156297 261256 186693 04.March 
18110 38618 61296 116633 171246 80040 209033 161740 275334 199762 02.March 
23371 55650 66521 132362 186213 80461 228034 165235 291597 207258 01.March 
21837 44872 96201 101280 196627 76078 209948 146743 238007 171731 26.February 
20950 43462 63324 125457 170804 83206 222886 150259 272400 177643 28.January 
15274 31917 41515 82211 121186 57603 155401 106571 198155 132585 26.January 
20999.5 42725 64341 139469 162653 75792.5 192850 126124.5 231975 195830 22.January 
20444.73 44774.48 64785.68 119151.7 171394.1 72385.5 205552.8 152720.9 262913.6 180203.8 average 
2763.133 5968.215 12631.26 13325.36 18663.66 7054.084 22814.3 22782.4 31639.27 23034.14 standard deviation 
13.52% 13.33% 19.50% 11.18% 10.89% 9.75% 11.10% 14.92% 12.03% 12.78% %stdev 
15.22% 17.75% 2.51% 19.23% 13.93% 6.97% 0.77% 13.17% 9.75% 11.54% %first/last 
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Annex E. Measurement results for different columns 
C18 Gravity SB 
Sample information Cyclic dinucleotides 
Code Organism ssp. Medium Phase Date of 
first 
culture
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C
A
M
P
 
c-
U
A
M
P
 
c-
C
G
M
P
 
c-
U
G
M
P
 
c-
d
i-
A
M
P
 
c-
A
G
M
P
 
c-
d
i-
G
M
P
 
#15a St. cohnii GH137 LB exponential 02.Mar 
  
0.45 1.02 
  
0.25 
   
#15b St. cohnii GH137 LB stationary 02.Mar 
   
0.97 
  
0.47 
   
#17a 
C. 
testosteroni 
KF-1 LB exponential 02.Mar 
 
0.46 
 
0.43 
 
0.62 
 
1.54 
 
0.27 
#17b 
C. 
testosteroni 
KF-1 LB stationary 02.Mar 0.13 0.19 
 
0.14 0.07 0.09 0.13 0.17 0.09 
 
#18a Ps. putida KT-2440 LB exponential 02.Mar 
      
1.71 
   
#18b Ps. putida KT-2440 LB stationary 02.Mar 
    
0.03 
 
0.05  0.04 0.51 
#4b B. subtilis DSM10 LB exponential 02.Mar 2.34 
  
2.77 
      
#4c B. subtilis DSM10 LB stationary 02.Mar 1.19 
         
#4d B. subtilis DSM10 MSgg biofilm 02.Mar 4.52 
 
2.80 0.46 
   
0.91 
  
#14a 
S. 
erythraea 
ATCC11635 
Medium 
65 
exponential 03.Mar 
  
11.48 
  
1.26 
   
0.99 
#14b 
S. 
erythraea 
ATCC11635 
Medium 
65 
stationary 03.Mar 
         
0.06 
#16a 
S. 
cerevisiae 
BY4741 YPAD exponential 12.Apr 
  
0.17 1.97 0.33 
 
0.34 0.35 0.34 0.41 
#16b 
S. 
cerevisiae 
BY4741 YPAD stationary 12.Apr 
          
                                                 
2
 Second preparation was strictli in 14working days after the first 
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Sample information Cyclic dinucleotides 
Code Organism ssp. Medium Phase Date of 
first 
culture
2
 
c-
d
i-
C
M
P
 
c-
C
U
M
P
 
c-
d
i-
U
M
P
 
c-
C
A
M
P
 
c-
U
A
M
P
 
c-
C
G
M
P
 
c-
U
G
M
P
 
c-
d
i-
A
M
P
 
c-
A
G
M
P
 
c-
d
i-
G
M
P
 
#19a 
C. 
crescentus 
CB15N 
(NA1000) 
PYE exponential 15.Apr 
  
4.84 1.02 
     
1.24 
#19b 
C. 
crescentus 
CB15N 
(NA1000) 
PYE stationary 15.Apr 0.52 
 
3.41 0.30 0.19 0.19 0.21 0.34 0.16 0.28 
#20a
3
 
X. 
campestris 
ATCC 
33913 
Medium 
54, 
stationary 10.May 
 
2.84 1.71 1.41 0.63 3.80 1.29 0.88 0.70 0.80 
#20b 
X. 
campestris 
ATCC 
33913 
Medium 
54, 
stationary 10.May 
   
0.12 
 
0.60 2.90 0.12 2.40 0.25 
#20c 
X. 
campestris 
ATCC 
33913 
TY stationary 11.May 
   
1.28 
  
3.45 1.41 0.49 0.34 
#20d 
X. 
campestris 
ATCC 
33913 
TY stationary 11.May 
      
3.17 2.30 0.75 0.26 
 
  
                                                 
3
 X. campestris is measured only once so far 
45 
 
C18 Isis 
Sample information Cyclic dinucleotides 
Code Organism ssp. Medium Phase Date of 
first 
culture 
c-
d
i-
C
M
P
 
c-
C
U
M
P
 
c-
d
i-
U
M
P
 
c-
C
A
M
P
 
c-
U
A
M
P
 
c-
C
G
M
P
 
c-
U
G
M
P
 
c-
d
i-
A
M
P
 
c-
A
G
M
P
 
c-
d
i-
G
M
P
 
#15a St. cohnii GH137 LB exponential 02.Mar 
  
yes yes 
  
  
  
#15b St. cohnii GH137 LB stationary 02.Mar 
 
yes  yes       
#17a 
C. 
testosteroni 
KF-1 LB exponential 02.Mar 
 
yes 
 
yes 
   
yes 
 
yes 
#17b 
C. 
testosteroni 
KF-1 LB stationary 02.Mar          yes 
#18a Ps. putida KT-2440 LB exponential 02.Mar 
      
yes 
   
#18b Ps. putida KT-2440 LB stationary 02.Mar 
    
 
  
  yes 
#4b B. subtilis DSM10 LB exponential 02.Mar  
  
yes 
      
#4c B. subtilis DSM10 LB stationary 02.Mar yes 
    
yes 
    
#4d B. subtilis DSM10 MSgg biofilm 02.Mar yes 
 
yes  
   
 yes 
 
#14a 
S. 
erythraea 
ATCC11635 
Medium 
65 
exponential 03.Mar 
  
yes 
  
yes 
   
yes 
#14b 
S. 
erythraea 
ATCC11635 
Medium 
65 
stationary 03.Mar 
       
yes 
  
#16a 
S. 
cerevisiae 
BY4741 YPAD exponential 12.Apr 
 
yes  yes  
 
   yes 
#16b 
S. 
cerevisiae 
BY4741 YPAD stationary 12.Apr 
          
#19a 
C. 
crescentus 
CB15N 
(NA1000) 
PYE exponential 15.Apr 
  
yes yes 
     
yes 
#19b 
C. 
crescentus 
CB15N 
(NA1000) 
PYE stationary 15.Apr  
 
yes        
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Sample information Cyclic dinucleotides 
Code Organism ssp. Medium Phase Date of 
first 
culture 
c-
d
i-
C
M
P
 
c-
C
U
M
P
 
c-
d
i-
U
M
P
 
c-
C
A
M
P
 
c-
U
A
M
P
 
c-
C
G
M
P
 
c-
U
G
M
P
 
c-
d
i-
A
M
P
 
c-
A
G
M
P
 
c-
d
i-
G
M
P
 
#20a 
X. 
campestris 
ATCC 
33913 
Medium 
54, 
stationary 10.May 
 
yes 
 
yes yes yes yes yes  yes 
#20b 
X. 
campestris 
ATCC 
33913 
Medium 
54, 
stationary 10.May 
 
yes yes  
 
yes yes  yes  
#20c 
X. 
campestris 
ATCC 
33913 
TY stationary 11.May yes 
  
yes 
  
yes yes yes  
#20d 
X. 
campestris 
ATCC 
33913 
TY stationary 11.May 
   
yes 
  
yes yes yes  
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INFORMATION SHEET 
 
Pealkiri: Bakterikultuurides tsükliliste dinukleotiidide esmase identifitseerimismetoodika 
arendamine. 
Kokkuvõte: Tsüklilised dinukleotiidid on eeldatavasti teisased virgatsained bakterites. 
Mõned selle aineklassi teadaolevad ühendid on olulisel kohal paljudes rakus toimuvates 
protsessides alates raku elutsüklist kuni patogeneesini. In vivo ühendeid sünteesitakse 
tsükliliste dinukleotiidi tsüklaaside ja lagundatakse spetsiifiliste fosfodiesteraaside 
vahendusel. Paljud teadaolevad sellesse klassi kuuluvad valgud ei interakteeru tuntud 
tsükliliste dinukleotiididega, mis viitab sellele, et rakus võib esineda senitundmatuid tsüklilisi 
dinukleotiide. Käesolevas töös töötati välja mitut kolonni kasutav vedelikkromatograafia-
massispektromeetriline metoodika huvipakkuvate ainete määramiseks bakteriekstraktist. 
Metoodika aluseks on sünteesitud tsükliliste nukleotiidide standardained. Väljatöötatud 
analüüsimetoodika avastamispiir on madalam, kui teaduskirjanduses siiani avaldatud üksikute 
tsükliliste dinukleotiidide metoodikatel. Metoodika toimivuse kinnituseks uuriti mitmeid 
bakterikultuure, mis teadaolevalt produtseerivad diguanülaadi või diadenülaadi tsüklilisi 
dinukleotiide. Samuti näidati, et mõnede tsükliliste dinukleotiidide tase sõltub bakterite 
kasvufaasist. 
Märksõnad: bakterid: ainevahetus, tsüklilised dinukleotiidid, c-di-GMP, HPLC, LC-MS, 
kvalitatiivne analüüs, teisane virgatsaine. 
 
Title: Development of method for preliminary identification of cyclic dinucleotides in 
bacterial cultures 
Summary: Cyclic dinucleotides are perspective second messengers in Bacteria. Known 
compounds of the class play various roles in many processes in bacteria from cell cycle to 
pathogenesis. In vivo compounds are synthesized with cyclic dinucleotide cyclases and 
degrade with specific phosphodiesterases. Many of discovered proteins of these classes do not 
interact with known cyclic dinucleotide compounds, which suggest another compounds of the 
class may be also in the bacterial cell. In this work a method was developed , based on liquid 
chromatography coupled mass spectrometry with several columns, which is capable to 
distinguish possible compound of interest in the bacterial extract based on the chemically 
synthesized compounds of the class. Method is shown to have LOD lower, than in any 
method proposed before for single cyclic dinucleotide compound. As a proof of principle, 
several bacteria reported to produce cyclic diguanylate or cyclic diadenylate were tested. In 
addition, it was demonstrated that levels of some of cyclic dinucleotides are dependent on 
growing phase of bacteria.  
Keywords: Bacteria: metabolism, cyclic dinucleotides, c-di-GMP, HPLC, LC-MS, 
qualitative analysis, second messenger.  
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